@TAOSynergies TAO Synergies Inc.

TAO Synergies Inc. posts on X about $snpx, tao, $taox, science the most. They currently have [-----] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

Engagements: [--] #

• [--] Week [---] +52%
• [--] Month [-----] -53%
• [--] Months [-------] +35%
• [--] Year [-------] +8,256%

Mentions: [--] #

• [--] Week [--] +24%
• [--] Month [--] -6.10%
• [--] Months [--] +235%
• [--] Year [--] +518%

Followers: [-----] #

• [--] Week [-----] +0.04%
• [--] Month [-----] +0.33%
• [--] Months [-----] +58%
• [--] Year [-----] +1,967%

CreatorRank: undefined #

Social Influence

Social category influence stocks 100% cryptocurrencies 31% finance 16% exchanges 4% travel destinations 1% technology brands 1%

Social topic influence $snpx #1, tao #1811, $taox #7, science 25%, ai 24%, $tao #560, bittensor #677, crypto 16%, health 13%, decentralized #2717

Top accounts mentioned or mentioned by @jaltucher @yumagroup @bittingthembits @bitgo @evanmalanga @victor_crypto_2 @cryptodotnews @albenakostova @yumagroups @journalad @lsuhealthno @themarkettunnel @gmx3011 @paulieval @dcgco @realcoincentral @theblock @cointimeglobal @cryptoamb @taodailyio

Top assets mentioned Tao Synergies Inc. (TAOX) Bittensor (TAO) Coinbase Global Inc. (COIN)

Top Social Posts

Top posts by engagements in the last [--] hours

"Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy Appoints @BitGo as Custodian and Commences Yield Generation Through Staking. Read the press release here: $SNPX $TAO #Crypto https://bit.ly/4ncFon7 https://bit.ly/4ncFon7"
X Link 2025-06-24T13:51Z [----] followers, 86.5K engagements

"We are excited to announce our name change to TAO Synergies Inc. and its new ticker symbol $TAOX a rebranding that aligns with our exclusive focus on $TAO and its long-term growth potential. Read the press release: $SNPX #AI #MachineLearning #Crypto https://bit.ly/44lxH5u https://bit.ly/44lxH5u"
X Link 2025-06-26T13:46Z [----] followers, 107.5K engagements

"Synaptogenix has begun to generate revenue through $TAO staking from qualified custody with BitGo enabling the company to generate yield while maintaining the highest standards of security and regulatory compliance. Read more: $SNPX #TAO #Crypto https://prn.to/3GeNqLm https://prn.to/3GeNqLm"
X Link 2025-06-30T13:30Z [----] followers, 10.3K engagements

"RECAP: TAO Synergies launched new ticker $TAOX yesterday. 🚀 The first pure-play public company focused on the convergence between cryptocurrency and #AI. Strategy: Exclusively acquiring and staking TAO cryptocurrency. $TAOX Full details: https://bit.ly/4nufPxU https://bit.ly/4nufPxU"
X Link 2025-07-02T15:51Z [----] followers, 22.4K engagements

"TAO Synergies Acquires $10 Million of #Bittensor ($TAO) to Become Largest Publicly Traded $TAO Holder. Read more here: $TAOX #TAO #AI #Crypto #DigitalAssets #Tech #Innovation https://bit.ly/4lySY2I https://bit.ly/4lySY2I"
X Link 2025-07-17T13:29Z [----] followers, 64.3K engagements

"$TAOX acquired $10M in #Bittensor $TAO tokens making us the largest publicly traded pure-play #TAO holder globally. @Cryptodotnews captures how were leveraging decentralized #AI seeing it as the "Internet in 1996" moment: https://bit.ly/4l5xA4p https://bit.ly/4l5xA4p"
X Link 2025-07-21T13:15Z [----] followers, [----] engagements

"TAO Synergies Accelerates Decentralized AI Treasury Strategy with [-----] #Bittensor ($TAO) Tokens Acquired and Earned Through Staking to Date. $TAOX is the largest publicly traded TAO pure-play treasury company. Read the press release: #AI https://bit.ly/40Tqhp6 https://bit.ly/40Tqhp6"
X Link 2025-08-06T13:43Z [----] followers, 34.4K engagements

"TAO Synergies Digital Assets Advisor @jaltucher Speaks at Google's Planet Scale Consumer AI Event. Read the press release here: $TAOX #Bittensor #AI https://bit.ly/46ryBzp https://bit.ly/46ryBzp"
X Link 2025-09-08T13:44Z [----] followers, 11.4K engagements

"TAO Synergies launches "The TAO Daily" the premier media platform for all things #Bittensor 🚀 New digital hub to educate engage and connect the growing TAO community and decentralized #AI contributors. Read the press release: $TAOX $TAO #Crypto https://bit.ly/4nE03j7 https://bit.ly/4nE03j7"
X Link 2025-09-22T13:35Z [----] followers, 52.6K engagements

"TAO Synergies announces $11 million private placement supported by existing stockholders TAO Strategy Advisor @jaltucher and new investor DCG. Read the press release: $TAOX https://bit.ly/46Pvq4R https://bit.ly/46Pvq4R"
X Link 2025-10-13T21:27Z [----] followers, 65.8K engagements

"TAO Synergies announced a $11M private placement supported by existing stockholders @jaltucher & @DCGco. Financing reinforces our commitment to expanding our $TAO holdings & participation in the #Bittensor ecosystem. Read more via @realcoincentral: $TAOX https://bit.ly/48u8RUH https://bit.ly/48u8RUH"
X Link 2025-10-14T15:59Z [----] followers, [----] engagements

"$TAOX secures $11M in private financing to advance strategic investments in $TAO tokens and #deAI. We seek to stake TAO for revenue generation and capital appreciation supporting our mission to create value for shareholders. Dive in via @TheBlock__: https://bit.ly/475qwPX https://bit.ly/475qwPX"
X Link 2025-10-14T16:45Z [----] followers, [----] engagements

"TAO Synergies Raises Bittensor ($TAO) Holdings to over [-----] Tokens Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency. Read the press release here: $TAOX #DeAI #Bittensor #Crypto #AI https://bit.ly/4ni8EHM https://bit.ly/4ni8EHM"
X Link 2025-10-20T13:39Z [----] followers, 40.5K engagements

"$TAOX total TAO holdings have increased to [-----] tokens further solidifying TAO Synergies' position as the largest publicly traded pure-play holder of Bittensor. Read more via @Cointime_global: $TAOX #CryptoMarket #AI #Bittensor https://www.cointime.ai/flash-news/tao-synergies-33061 https://www.cointime.ai/flash-news/tao-synergies-33061"
X Link 2025-10-21T13:30Z [----] followers, [----] engagements

"By increasing holdings to [-----] tokens $TAOX further solidifies our position as the largest publicly traded pure-play holder of Bittensor $TAO the groundbreaking protocol powering decentralized AI innovation. Coverage by: @Albena_Kostova #Bittensor https://bit.ly/47jmi7H https://bit.ly/47jmi7H"
X Link 2025-10-22T17:16Z [----] followers, [----] engagements

"TAO Synergies is accumulating $TAO tokens expanding its holdings to over [-----]. 🚀 via @CryptoAmb: #Crypto #Bittensor https://bit.ly/4hm1LE9 https://bit.ly/4hm1LE9"
X Link 2025-10-22T18:00Z [----] followers, 15.6K engagements

"TAO Synergies announces initial $750000 investment in Yuma Asset Management's Bittensor Subnet Funds enhancing the companys exposure to subnets in the #Bittensor ecosystem. Read the press release: $TAOX #Crypto #AI @yumagroup https://prn.to/3JDB3Kv https://prn.to/3JDB3Kv"
X Link 2025-11-04T14:26Z [----] followers, 123.3K engagements

"Deepening the #Bittensor ecosystem play: ✅ 60000+ TAO staked ✅ $750K in @YumaGroup subnet funds ✅ Staking TAO for base rewards then layering on subnet alpha to supercharge growth $TAOX shareholders now have exposure to 100+ active subnets. Details: https://prn.to/3JDB3Kv https://prn.to/3JDB3Kv"
X Link 2025-11-05T14:30Z [----] followers, 23.6K engagements

"Decentralized AI isnt the future it's unfolding right now. - @jaltucher 💡 ICYMI $TAOX invested $750K in Yumas subnet funds to amplify TAO exposure. Read 👉 https://prn.to/3JDB3Kv https://prn.to/3JDB3Kv"
X Link 2025-11-06T14:30Z [----] followers, [----] engagements

"TAO Synergies 🤝 @yumagroup to host livestream on X featuring @jaltucher and @EvanMalanga. ⚡ Bittensor (TAO) and DeAI Innovation 📅 Tuesday November [--] [----] 12:15 p.m. ET. More details: $TAOX https://bit.ly/4o7VzBp https://bit.ly/4o7VzBp"
X Link 2025-11-18T15:11Z [----] followers, [----] engagements

"Join us today at 12:15 p.m. ET for a LIVE Investor Spotlight into $TAO decentralized AI and network outlook as the TAO halving approaches with our Digital Asset Treasury Strategist @jaltucher and @yumagroups @EvanMalanga. 👇 $TAOX https://x.com/i/broadcasts/1yNGabqBppdJj https://x.com/i/broadcasts/1yNGabqBppdJj"
X Link 2025-11-18T16:40Z [----] followers, 15K engagements

"In case you missed it @yumagroups CRO @EvanMalanga and @jaltucher discuss the future of $TAO subnet tokens and the halving. Check out the recap via @taodaily_io. 🔗 $TAOX https://bit.ly/49nmgOK https://bit.ly/49nmgOK"
X Link 2025-11-19T18:45Z [----] followers, [----] engagements

"Synaptogenix to Present at Hanson Wade 10th Annual Neurodegenerative Drug Development Summit. Read the full press release here: $SNPX #Alzheimers #AlzheimersAwareness #Biopharma https://www.prnewswire.com/news-releases/synaptogenix-to-present-at-hanson-wade-10th-annual-neurodegenerative-drug-development-summit-301512588.html https://www.prnewswire.com/news-releases/synaptogenix-to-present-at-hanson-wade-10th-annual-neurodegenerative-drug-development-summit-301512588.html"
X Link 2022-03-29T13:50Z [----] followers, [--] engagements

"New Peer Reviewed Article Demonstrates Extended Therapeutic Potential of Synaptogenix's Bryostatin for #AlzheimersDisease. Read the full news release here: $SNPX #AlzheimersDisease #Pharma #Neuroscience https://www.prnewswire.com/news-releases/new-peer-reviewed-article-demonstrates-extended-therapeutic-potential-of-synaptogenixs-bryostatin-for-alzheimers-disease-301517850.html https://www.prnewswire.com/news-releases/new-peer-reviewed-article-demonstrates-extended-therapeutic-potential-of-synaptogenixs-bryostatin-for-alzheimers-disease-301517850.html"
X Link 2022-04-05T13:40Z [----] followers, [--] engagements

"Why #Synaptic Signals Are More Unequal Than First Thought. Read more via @tech_networks: $SNPX #Pharma #NeurodegenerativeDiseases #Science #BrainHealth https://www.technologynetworks.com/neuroscience/news/why-synaptic-signals-are-more-unequal-than-first-thought-358864 https://www.technologynetworks.com/neuroscience/news/why-synaptic-signals-are-more-unequal-than-first-thought-358864"
X Link 2022-04-06T15:07Z [----] followers, [--] engagements

"Bryostatin drug target Protein Kinase C (PKC) Epsilon tracks the cognitive benefit of the #patient. It is clinically meaningful improvement in cognition MMSE and ADL-severe correlates with an increase in PKC Epsilon. $SNPX #Pharma #Science #DrugDiscovery https://www.synaptogen.com/#science https://www.synaptogen.com/#science"
X Link 2022-04-08T15:00Z [----] followers, [--] engagements

"#DYK Bryostatin demonstrated a favorable safety profile across both completed Phase II Pilot #Alzheimers disease trials Learn more: $SNPX #Pharma #Science #Health #DrugDiscovery http://www.synaptogen.com/#science http://www.synaptogen.com/#science"
X Link 2022-04-13T15:12Z [----] followers, [--] engagements

"Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for #MultipleSclerosis. Find out more about our IND Application expected in the first half of 2022: $SNPX #Pharma #Science #Health https://www.prnewswire.com/news-releases/synaptogenix-moves-forward-with-clinical-development-plans-for-bryostatin-1-as-a-treatment-for-multiple-sclerosis-301488603.html https://www.prnewswire.com/news-releases/synaptogenix-moves-forward-with-clinical-development-plans-for-bryostatin-1-as-a-treatment-for-multiple-sclerosis-301488603.html"
X Link 2022-04-15T14:47Z [----] followers, [--] engagements

"Synaptogenix Completes Patient Enrollment in NIH Sponsored Phase 2b #Alzheimers Disease Trial Read the full news release here: $SNPX #AlzheimersDisease #Healthcare #Health https://www.prnewswire.com/news-releases/synaptogenix-completes-patient-enrollment-in-nih-sponsored-phase-2b-alzheimers-disease-trial-301528016.html https://www.prnewswire.com/news-releases/synaptogenix-completes-patient-enrollment-in-nih-sponsored-phase-2b-alzheimers-disease-trial-301528016.html"
X Link 2022-04-19T14:00Z [----] followers, [--] engagements

"Which indication for Bryostatin are you interested in learning more about $SNPX #Biotech #Science #Health #DrugDiscovery Alzheimers disease Fragile X Syndrome/Autism Parkinsons Disease Multiple Sclerosis Alzheimers disease Fragile X Syndrome/Autism Parkinsons Disease Multiple Sclerosis"
X Link 2022-05-20T17:59Z [----] followers, [--] engagements

"Our #technology developed over a decade through funding of $200M+ by Blanchette Rockefeller Neurosciences Institute and the National Institutes of Health (NIH). Read more: $SNPX #Pharma #NeurodegenerativeDiseases #Science #Health https://www.synaptogen.com/ https://www.synaptogen.com/"
X Link 2022-05-26T14:49Z [----] followers, [--] engagements

""Evidence is growing and continues to support Bryostatin-1 as a potential treatment for #Alzheimers disease. We are excited today to announce the completion of our Phase 2b enrollment" CEO Dr. Alan Tuchman. Read more: $SNPX #Biotech #Science #Health https://www.prnewswire.com/news-releases/synaptogenix-completes-patient-enrollment-in-nih-sponsored-phase-2b-alzheimers-disease-trial-301528016.html https://www.prnewswire.com/news-releases/synaptogenix-completes-patient-enrollment-in-nih-sponsored-phase-2b-alzheimers-disease-trial-301528016.html"
X Link 2022-06-03T15:14Z [----] followers, [--] engagements

"Bryostatin demonstrated a favorable safety profile across both completed Phase II Pilot #Alzheimers disease trials. Learn more about our current trial: $SNPX #Biotech #NeurodegenerativeDiseases #Science https://www.synaptogen.com/#science https://www.synaptogen.com/#science"
X Link 2022-06-14T14:51Z [----] followers, [--] engagements

"Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes #synaptogenic treatment approaches for serious and difficult-to-treat diseases. $SNPX #Biotech #Science #Health #DrugDiscovery #Alzheimers https://www.synaptogen.com/ https://www.synaptogen.com/"
X Link 2022-06-23T15:10Z [----] followers, [--] engagements

"Meet our Chief Science Officer Dr. Daniel Alkon A leader in the field Dr. Alkon comes to Synaptogenix after [--] years directing programs on the molecular basis of associative memory at the National Neurologic Institute of NIH. More here: $SNPX #Biotech https://www.synaptogen.com/#team https://www.synaptogen.com/#team"
X Link 2022-07-13T15:10Z [----] followers, [--] engagements

"Synaptogenix Advances Dosing of First Patient in Dose Optimization Clinical Trial in Preparation for NIH-Sponsored Phase [--] Alzheimer's Disease Trial Data. Read the full news release here: $SNPX #Alzheimers #Research https://prn.to/3IP3Cjv https://prn.to/3IP3Cjv"
X Link 2022-07-20T13:50Z [----] followers, [--] engagements

"Synaptogenix Announces Corporate Update Conference Call. Read the full news release here: $SNPX #Biotechnology https://bit.ly/3oigDZd https://bit.ly/3oigDZd"
X Link 2022-07-21T13:52Z [----] followers, [--] engagements

"Our key accomplishments of our clinical development plan consist of: [--]. Safety Profile [--]. Cognitive improvement over baseline not just a slowing of the rate of decline and [--]. Effect is persistent at least one month after dosing. $SNPX #Biotech #Science"
X Link 2022-07-22T14:53Z [----] followers, [--] engagements

"Did you miss our corporate update conference call A replay is available for your convenience. Hear from Synaptogenix's Chief Executive Officer Dr. Alan Tuchman and its President and Chief Scientific Officer Dr. Daniel Alkon"
X Link 2022-07-27T19:54Z [----] followers, [--] engagements

"Evidence is growing and continues to support Bryostatin-1 as a potential treatment for #Alzheimer's disease. Our team is continuously working towards top line results expected on the horizon. Check out our recent research article here: $SNPX #Science https://content.iospress.com/articles/journal-of-alzheimers-disease/jad215545 https://content.iospress.com/articles/journal-of-alzheimers-disease/jad215545"
X Link 2022-07-29T14:51Z [----] followers, [--] engagements

"Our Pilot Phase II AD Study key findings have revealed the effect is the difference between Bryostatin with no memantine vs. the placebo with no memantine and vs. Bryostatin on memantine. More about Bryostatin here: $SNPX #Science https://www.synaptogen.com/#science https://www.synaptogen.com/#science"
X Link 2022-08-04T15:06Z [----] followers, [--] engagements

"Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network. Read the full news release here: $SNPX #Biopharma #Science https://www.prnewswire.com/news-releases/synaptogenix-announces-live-appearance-of-its-president-and-cso-on-streaming-financial-news-network-301604803.html https://www.prnewswire.com/news-releases/synaptogenix-announces-live-appearance-of-its-president-and-cso-on-streaming-financial-news-network-301604803.html"
X Link 2022-08-12T13:43Z [----] followers, [--] engagements

"Our therapeutic drug to treat #Alzheimers Bryostatin recently showed a statistically significant improvement in the treatment group that was not observed in the placebo group in two pilot placebo-controlled Phase [--] trials. Learn about the data: $SNPX https://www.prnewswire.com/news-releases/synaptogenix-advances-dosing-of-first-patient-in-dose-optimization-clinical-trial-in-preparation-for-nih-sponsored-phase-2-alzheimers-disease-trial-data-301589937.html"
X Link 2022-08-23T15:09Z [----] followers, [--] engagements

"#ICYMI Our President and CSO Dr. Daniel L. Alkon recently joined @TDANetwork's Morning Trade Live with @OJRenick. Watch as Dr. Alkon discusses details about our fight against #Alzheimer's here: $SNPX #Biopharma #Science https://bit.ly/3pHI6nO https://bit.ly/3pHI6nO"
X Link 2022-08-25T15:15Z [----] followers, [--] engagements

"We are leveraging Bryostatin-1 for novel regenerative therapeutics for #neurodegenerative diseases and developmental disorders which has shown to promote neuronal health and synaptic regeneration. More here our #science here: $SNPX #Biotech #Biotechnology https://www.synaptogen.com/#science https://www.synaptogen.com/#science"
X Link 2022-09-01T14:55Z [----] followers, [--] engagements

"What are Synapses Synapses are tiny connectors that permit a neuron (or nerve cell) to pass an electrical or chemical signal to another neuron. Trillions of synapses form networks in the brain. Learn more here: $SNPX #Science #Biotech https://www.synaptogen.com/#science https://www.synaptogen.com/#science"
X Link 2022-09-13T14:52Z [----] followers, [--] engagements

"Synaptic loss is the major pathologic correlate of #Alzheimersdisease and other dementias and has been shown to occur in the very early stages of such diseases. Learn more about our #science here: $SNPX #Biotech #AD https://www.synaptogen.com/#science https://www.synaptogen.com/#science"
X Link 2022-09-20T14:52Z [----] followers, [--] engagements

"Synaptogenix Welcomes Lecanemab Phase [--] Trial Results. Read the full news release here: $SNPX #Biopharma #Pharma #Science #Neurodegenerative #Alzheimers #AlzheimersAwareness https://ir.synaptogen.com/single-news-releases/webmasterId=104427&qmodStoryID=8803374928960720 https://ir.synaptogen.com/single-news-releases/webmasterId=104427&qmodStoryID=8803374928960720"
X Link 2022-09-28T16:31Z [----] followers, [--] engagements

"SAB Spotlight Meet Chairman Dr. Perry. He is recognized in the field of #Alzheimers disease research particularly for his work on oxidative #stress. He is also the current and founding editor-in-chief for @journal_ad. $SNPX https://www.synaptogen.com/#team https://www.synaptogen.com/#team"
X Link 2022-09-29T19:33Z [----] followers, [--] engagements

"Did you know that #Synaptic loss is the major pathologic correlate #dementias They have been shown to occur in the very early stages of such diseases. Learn more here: $SNPX #Biotech #NeurodegenerativeDiseases #DrugDiscovery #ClinicalTrial #Research https://www.synaptogen.com/#pipeline https://www.synaptogen.com/#pipeline"
X Link 2022-10-04T14:47Z [----] followers, [--] engagements

"We consider ourselves pioneers of restorative therapeutics due to our extensive toxicity safety profile biomarkers that track #cognitive improvement valuable partnerships and more. Meet our team of experienced professionals: $SNPX #Biotech #Science https://www.synaptogen.com/#team https://www.synaptogen.com/#team"
X Link 2022-10-06T15:07Z [----] followers, [--] engagements

"#ICYMI We are expecting data from our Phase [--] clinical trial of Bryostatin-1 for advanced Alzheimer's disease in Q4 [----]. Learn more: $SNPX #Biopharma #Pharma #Science #Neurodegenerative #Alzheimers #AlzheimersAwareness https://bit.ly/3V8Na3l https://bit.ly/3V8Na3l"
X Link 2022-10-13T14:47Z [----] followers, [--] engagements

"SAB Spotlight Paul Coleman PhD is an Associate of McKnight Brain Institute at @uarizona and a research professor at UAs Biodesign Institute. He provides insight into how synaptic network loss and dysfunction are correlated with cognitive decline. $SNPX https://www.synaptogen.com/#team https://www.synaptogen.com/#team"
X Link 2022-10-18T15:09Z [----] followers, [--] engagements

"Synaptogenix to Present at ThinkEquity Investor Conference on October [--] [----]. Read the full news release here: $SNPX #BusinessUpdate https://prn.to/3VCQRhY https://prn.to/3VCQRhY"
X Link 2022-10-19T13:46Z [----] followers, [--] engagements

"Synaptic loss is the major pathologic correlate of #Alzheimersdisease and other #dementias and has been shown to occur in the very early stages of such diseases. Learn about Bryostatin-1s mission to help: $SNPX #Biopharma #Neurodegenerative #Alzheimers https://www.synaptogen.com/#pipeline https://www.synaptogen.com/#pipeline"
X Link 2022-10-20T14:54Z [----] followers, [--] engagements

"Chief Scientific Officer Daniel L. Alkon M.D. will deliver a presentation at the ThinkEquity Conference in #NYC today discussing Bryostatin-1 for the treatment of #Alzheimer's. Topline data is expected in Q4. Investors may register here: $SNPX https://bit.ly/3ToHmAS https://bit.ly/3ToHmAS"
X Link 2022-10-26T11:30Z [----] followers, [--] engagements

"Leadership Spotlight: Joshua Silverman joined Synaptogenix as a Director in [----] and currently serves as our Board Chairman. He brings over a decade of experience in the markets and unparalleled business acumen. Thank you for being part of our team. $SNPX https://bit.ly/3MVX5W7 https://bit.ly/3MVX5W7"
X Link 2022-10-27T15:15Z [----] followers, [--] engagements

"Synapses allow #neurons to communicate with each other effectively. Fewer or defective synapses mean less brain connectivity a weaker nervous system and impaired cognition. Learn how Bryostatin helps promote #neuronal health and synaptic regeneration: https://www.synaptogen.com/#pipeline https://www.synaptogen.com/#pipeline"
X Link 2022-11-01T14:54Z [----] followers, [--] engagements

"As we advance our pipeline we are grateful to have received funding from the Blanchette Rockefeller Neurosciences Institute and the National Institutes of Health. Learn more about our partnerships as we continue to further our clinical trials: $SNPX https://www.synaptogen.com/#who_we_are https://www.synaptogen.com/#who_we_are"
X Link 2022-11-03T14:55Z [----] followers, [--] engagements

"#ICYMI Synaptogenix is expecting data from our Phase [--] #clinicaltrial of Bryostatin-1 for advanced #Alzheimer's Disease in Q4 [----]. Learn more: $SNPX #Biotech #NeurodegenerativeDiseases #Science https://bit.ly/3DM3SgX https://bit.ly/3DM3SgX"
X Link 2022-11-08T14:46Z [----] followers, [--] engagements

"The key accomplishments of our clinical development plan include Safety Profiles A cognitive improvement over baseline not just a slowing of the rate of decline The effect is persistent for at least one month after dosing Learn more: $SNPX https://bit.ly/3FUg9m3 https://bit.ly/3FUg9m3"
X Link 2022-11-10T14:51Z [----] followers, [--] engagements

"Using patients who have moderate and moderately severe #Alzheimers Disease in our NIH-Supported Phase II #ClinicalTrial helps eliminates variability. Learn more about Bryostantin-1 for the treatment of #AD: $SNPX #Biotech #Neurology #Research https://bit.ly/3TfmLP8 https://bit.ly/3TfmLP8"
X Link 2022-11-17T15:06Z [----] followers, [--] engagements

"Synaptogenix expects topline data from our NIH supported Phase [--] clinical trial for advanced #Alzheimers disease patients during the current quarter. Keep up with our latest developments here: $SNPX #AD #AlzheimersDisease #Biopharma https://ir.synaptogen.com/news-releases/ https://ir.synaptogen.com/news-releases/"
X Link 2022-11-21T19:53Z [----] followers, [--] engagements

"Why are Synapses so important When abundant and working correctly synapses allow neurons to communicate with each other effectively. This means our nervous system is performing well and with sharp cognitive functioning. Learn more: $SNPX #Science https://www.synaptogen.com/#science https://www.synaptogen.com/#science"
X Link 2022-11-23T14:50Z [----] followers, [--] engagements

"Meet our Executive Director of Clinical Ops Elaine Grenier. She brings 25+ years of experience in the #pharma industry with management responsibility for #clinicaltrials in #oncology central nervous system and more. Meet our team: $SNPX #Biopharma https://www.synaptogen.com/#team https://www.synaptogen.com/#team"
X Link 2022-11-29T14:52Z [----] followers, [--] engagements

"Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes synaptogenic treatment approaches for serious and difficult-to-treat diseases. Learn more: $SNPX #NeurodegenerativeDiseases #Science #Biopharma https://www.synaptogen.com/#pipeline https://www.synaptogen.com/#pipeline"
X Link 2022-12-01T15:14Z [----] followers, [--] engagements

"SAB Spotlight Robert Howard is a professor of Old Age Psychiatry at University College London and #MentalHealth Lead of the @ucl Hospitals Biomedical Research Centre. His studies have shown the potential benefits of #dementia drugs. Learn more: $SNPX https://www.synaptogen.com/#team https://www.synaptogen.com/#team"
X Link 2022-12-08T14:51Z [----] followers, [--] engagements

"Our driving mission is to discover restorative novel therapeutics for patients with life-altering neurodegenerative diseases and developmental disorders including #Alzheimersdisease #Autism #MS #Parkinsons #Stroke and more. More: $SNPX #NueroTwitter https://www.synaptogen.com/#who_we_are https://www.synaptogen.com/#who_we_are"
X Link 2022-12-13T14:55Z [----] followers, [--] engagements

"Our lead drug candidate Bryostatin promotes #neuronal health and synaptic regeneration in patients with moderate to severe #Alzheimersdisease. Learn more: $SNPX #Biotech #NeuroTwitter https://www.synaptogen.com/#pipeline https://www.synaptogen.com/#pipeline"
X Link 2022-12-15T15:10Z [----] followers, [--] engagements

"Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience. Read the full news release here: $SNPX #Neuroscience @IBROorg https://www.prnewswire.com/news-releases/synaptogenix-abstract-highlighting-bryostatin-1-benefits-in-severe-alzheimers-disease-accepted-for-presentation-at-11th-international-brain-research-organization-world-congress-of-neuroscience-301876581.html"
X Link 2023-07-13T14:43Z [----] followers, [---] engagements

"Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study. Read the full news release here: $SNPX #NeurodegenerativeDiseases #Science #Biopharma #NeuroTwitter https://ir.synaptogen.com/qmodStoryID=8786652595757625 https://ir.synaptogen.com/qmodStoryID=8786652595757625"
X Link 2023-09-07T14:36Z [----] followers, [---] engagements

"(1/5) Dr. Alan Tuchman CEO of Synaptogenix comments on the safe significant and persistent benefits of the 6-month Bryostatin trial for patients with advanced Alzheimers Disease. $SNPX"
X Link 2023-09-28T17:22Z [----] followers, [---] engagements

"Big news for Synaptogenix A new study on the companys drug Bryostatin has shown no significant cognitive decline in patients throughout the 6-month trial. More details via @journal_ad: $SNPX https://content.iospress.com/articles/journal-of-alzheimers-disease/jad230868 https://content.iospress.com/articles/journal-of-alzheimers-disease/jad230868"
X Link 2023-10-03T16:06Z [----] followers, [---] engagements

"(1/3) Synaptogenix recently shared findings from our Phase [--] trial on a drug called Bryostatin-1 for #AlzheimersDisease. $SNPX"
X Link 2023-10-06T19:57Z [----] followers, [---] engagements

"Synaptogenix is pleased to announce a new partnership with Cannasoul Analytics Ltd. in support of research and development of pharmaceutical therapeutics. Read here for more details: $SNPX #Biotech #Pharma https://bit.ly/3MsJo25 https://bit.ly/3MsJo25"
X Link 2023-11-02T13:33Z [----] followers, [---] engagements

"Synaptogenix Increases Stake in Innovative #Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics. Read the press release here: $SNPX #BusinessUpdate https://prn.to/4aM6ryr https://prn.to/4aM6ryr"
X Link 2024-04-09T14:02Z [----] followers, [---] engagements

"Synaptogenix increases #psilocybin stake with PsygaBio. Read more about our latest news by @WallandBroad via @greenmarketrpt: $SNPX #Biopharma #Psychedelics https://bit.ly/4aslWvV https://bit.ly/4aslWvV"
X Link 2024-04-11T19:09Z [----] followers, [----] engagements

"Thank you @PharmExec for featuring our news this week about our partnership with Cannasoul and increasing our stake in PsyaBio. Dive into the article here: $SNPX #Biopharma #Psychedelics https://bit.ly/3Ubs31Q https://bit.ly/3Ubs31Q"
X Link 2024-04-12T13:45Z [----] followers, [---] engagements

"Synaptogenix Announces FDA Authorization of IND Application for #ClinicalTrial for Bryostatin-1 in #MultipleSclerosis. Read the press release here: $SNPX #Neuroscience #Biopharma https://bit.ly/3L0l5Y3 https://bit.ly/3L0l5Y3"
X Link 2024-06-26T13:42Z [----] followers, [---] engagements

"Yesterday we announced that the FDA has authorized an IND application for Bryostatin-1 as a potential treatment for #multiplesclerosis. Read more in the press release here: $SNPX #ClinicalResearch #Neurology https://bit.ly/3L0l5Y3 https://bit.ly/3L0l5Y3"
X Link 2024-06-28T14:21Z [----] followers, [----] engagements

"Preclinical data suggest that Bryostatin-1 has promising potential as a therapeutic agent for #MS. Read more about the collaborative study that will evaluate the drug's potential to improve synaptic health and #cognitive function in MS patients: $SNPX https://bit.ly/3L0l5Y3 https://bit.ly/3L0l5Y3"
X Link 2024-07-01T13:30Z [----] followers, [---] engagements

"Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in #SpinalCordInjury. Read the press release here: $SNPX @LSUHealthNO #PreclinicalResearch #Biopharmaceutical #Neuroscience https://prn.to/46iaYrp https://prn.to/46iaYrp"
X Link 2024-07-18T13:43Z [----] followers, [---] engagements

"ICYMI: New collab to probe potential of fatty acid analogs in #Alzheimer's. Our collab with @LSUHealthNO will focus on #preclinical testing of our polyunsaturated fatty acid analogs for treating spinal cord injuries. More via @ThePharmaLetter: $SNPX https://bit.ly/3LTul0r https://bit.ly/3LTul0r"
X Link 2024-08-07T14:37Z [----] followers, [---] engagements

"Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength. Read the press release here: $SNPX https://prn.to/4gK6VrX https://prn.to/4gK6VrX"
X Link 2024-12-20T16:57Z [----] followers, [----] engagements

"Synaptogenix is pleased to announce the appointment of #crypto and AI expert to lead digital asset treasury strategy focused exclusively on top-valued #AI token. Read the press release: $SNPX $TAO #Bittensor @jaltucher https://bit.ly/4dXIFT1 https://bit.ly/4dXIFT1"
X Link 2025-06-09T13:43Z [----] followers, 85.3K engagements

"Well-known cryptocurrency and AI expert James Altucher will lead a TAO-based revenue generation strategy targeting staking yield and token appreciation for Synaptogenix. Missed the release Dive in here: $SNPX $TAO #AI #AIToken #Bittensor https://bit.ly/4dXIFT1 https://bit.ly/4dXIFT1"
X Link 2025-06-11T13:30Z [----] followers, [----] engagements

"Synaptogenix is targeting $100M in $TAO tokens and will be the only pure play focused exclusively on this leading #AI / #crypto token @beincrypto features our yield-generating digital asset strategy led by @jaltucher. $SNPX #Bittensor #TAO https://bit.ly/3FUV6SQ https://bit.ly/3FUV6SQ"
X Link 2025-06-11T17:27Z [----] followers, 50.9K engagements

"Synaptogenix targeting $100M in $TAO a move towards decentralized AI. We believe the fixed market supply of [--] million TAO tokens alongside rapidly increasing global demand for #AI development & adaptation makes TAO a compelling #cryptocurrency. $SNPX https://bit.ly/4ncqk94 https://bit.ly/4ncqk94"
X Link 2025-06-11T18:20Z [----] followers, [----] engagements

"This week we proudly unveiled our crypto treasury strategy centered exclusively on $TAO the native token of #Bittensor. We believe this will offer the best outlook for growth and adoption. Check out the feature in @crypto_briefing: $SNPX #Crypto https://bit.ly/45jyp5l https://bit.ly/45jyp5l"
X Link 2025-06-11T19:30Z [----] followers, [----] engagements

"TAO Synergies has selected @Bitgo to provide qualified custody staking & trading services for our $TAO holdings. This underscores our commitment to our #Al pure play #cryptostrategy & long-term conviction thesis for TAO. Read more: @cryptopaniccom: $TAOX https://bit.ly/44AuNuF https://bit.ly/44AuNuF"
X Link 2025-06-27T13:47Z [----] followers, [----] engagements

"TAO Synergies has officially begun its #AI / #crypto treasury strategy New trading symbol $TAOX effective Tuesday July [--] [----]. @beingcrypto features our partnership with @BitGo for custody and staking to generate yield: $SNPX #AI #Crypto https://bit.ly/4lrzn4b https://bit.ly/4lrzn4b"
X Link 2025-06-27T14:30Z [----] followers, [----] engagements

"This transition represents a pivotal moment in our commitment to #digitalassets positioning us to create long-term value for our shareholders" said Executive Chairman Joshua Silverman. New ticker $TAOX effective July 1st. #Crypto #Blockchain #AI https://bit.ly/44lxH5u https://bit.ly/44lxH5u"
X Link 2025-06-27T16:27Z [----] followers, [----] engagements

"On Tuesday July [--] [----] we will begin trading on the #Nasdaq under the new ticker symbol $TAOX. Check out our feature in @defiantnews about our AI-focused crypto treasury strategy: https://bit.ly/3ZUHFsZ https://bit.ly/3ZUHFsZ"
X Link 2025-06-30T13:15Z [----] followers, [----] engagements

"TAO Synergies (Formerly Synaptogenix) Begins Trading Under New #Nasdaq Stock Symbol "TAOX" Effective at Market Open Today. Read the press release here: $TAOX #TAO https://bit.ly/4nufPxU https://bit.ly/4nufPxU"
X Link 2025-07-01T13:42Z [----] followers, [----] engagements

"$TAOX acquired $10M of #Bittensor (TAO) becoming the largest publicly traded pure play TAO Holder. "#Decentralized #AI and TAO remind me of the Internet in 1996" @jaltucher Digital Asset Treasury Strategist. Coverage by @CoinDesk. Read more: #TAO https://bit.ly/40R25Ur https://bit.ly/40R25Ur"
X Link 2025-07-21T15:19Z [----] followers, [----] engagements

"ICYMI: TAO Synergies has acquired $10M of #Bittensor $TAO becoming the largest publicly traded pure-play #TAO holder. Read more about our ongoing strategy: $TAOX #DecentralizedAI #AI #DigitalAsset https://prn.to/3Um2pGL https://prn.to/3Um2pGL"
X Link 2025-07-23T14:00Z [----] followers, [----] engagements

"$TAOX has accumulated [-----] Bittensor (TAO) tokens to date as part of its differentiated digital asset treasury strategy. Read about our #crypto strategy anchored at the intersection of decentralized #AI and #blockchain via @cryptodotnews: https://bit.ly/40RvKgc https://bit.ly/40RvKgc"
X Link 2025-08-08T13:30Z [----] followers, [----] engagements

"The TAO Daily launches as a comprehensive media platform for #Bittensor and the TAO ecosystem. Features daily news subnet leader interviews tutorials and educational content. $TAOX $TAO #Crypto #AI https://bit.ly/4nE03j7 https://bit.ly/4nE03j7"
X Link 2025-09-26T17:34Z [----] followers, [----] engagements

"@Albena_Kostova @floragrowthcorp @CleanSpark_Inc @coinbase Thank you for covering our latest announcement"
X Link 2025-10-22T17:32Z [----] followers, [---] engagements

"RT @jaltucher: Finally I can start talking about how much I love the $TAO Subnets. This is a game changer for AI. With $TAOX we are going f"
X Link 2025-11-04T14:56Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing